Home » Topics » BioWorld Science

BioWorld Science
RSS

JMX-0293 inhibits tumor growth in preclinical models of TNBC

Dec. 13, 2018

Phase IIb T-Force GOLD study of valbenazine does not meet primary endpoint

Dec. 13, 2018

Novel model of ALS discounts protein transmission hypothesis in disease pathogenesis

Dec. 13, 2018

First subject enrolled in phase I/IIa study of AR-501

Dec. 13, 2018

Almirall and X-Chem to develop oral dermatological treatments

Dec. 13, 2018

FDA clears IND for Y-mAbs' bispecific GD2 antibody

Dec. 13, 2018

CEPI and Imperial College London partner to develop saRNA vaccine platform

Dec. 13, 2018

Novel pyrimidopyrimidinone derivative JND-3229 inhibits EGFR C797S mutant

Dec. 13, 2018

ABHD12 regulates immunostimulatory lipid pathways in vivo

Dec. 13, 2018

Kiniksa presents interim phase II data for rilonacept and initiates phase III RHAPSODY study

Dec. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...